In conclusion, we reported that the D1CC mouse model of RA‐ILD is considerably similar to RA‐ILD in humans, and it could be valuable as a model of lung fibrosis, using specific markers such as serum SP‐D and CT to detect treatment effects. This evidence concerns the gene SFTPD and interstitial lung disease.